Cargando…
Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study
BACKGROUND: The surviving sepsis campaign recommends consideration for extracorporeal membrane oxygenation (ECMO) in refractory septic shock. We aimed to define the benefit threshold of ECMO in pediatric septic shock. METHODS: Retrospective binational multicenter cohort study of all ICUs contributin...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937937/ https://www.ncbi.nlm.nih.gov/pubmed/31888705 http://dx.doi.org/10.1186/s13054-019-2685-1 |
_version_ | 1783483970920382464 |
---|---|
author | Schlapbach, Luregn J. Chiletti, Roberto Straney, Lahn Festa, Marino Alexander, Daniel Butt, Warwick MacLaren, Graeme |
author_facet | Schlapbach, Luregn J. Chiletti, Roberto Straney, Lahn Festa, Marino Alexander, Daniel Butt, Warwick MacLaren, Graeme |
author_sort | Schlapbach, Luregn J. |
collection | PubMed |
description | BACKGROUND: The surviving sepsis campaign recommends consideration for extracorporeal membrane oxygenation (ECMO) in refractory septic shock. We aimed to define the benefit threshold of ECMO in pediatric septic shock. METHODS: Retrospective binational multicenter cohort study of all ICUs contributing to the Australian and New Zealand Paediatric Intensive Care Registry. We included patients < 16 years admitted to ICU with sepsis and septic shock between 2002 and 2016. Sepsis-specific risk-adjusted models to establish ECMO benefit thresholds with mortality as the primary outcome were performed. Models were based on clinical variables available early after admission to ICU. Multivariate analyses were performed to identify predictors of survival in children treated with ECMO. RESULTS: Five thousand sixty-two children with sepsis and septic shock met eligibility criteria, of which 80 (1.6%) were treated with veno-arterial ECMO. A model based on 12 clinical variables predicted mortality with an AUROC of 0.879 (95% CI 0.864–0.895). The benefit threshold was calculated as 47.1% predicted risk of mortality. The observed mortality for children treated with ECMO below the threshold was 41.8% (23 deaths), compared to a predicted mortality of 30.0% as per the baseline model (16.5 deaths; standardized mortality rate 1.40, 95% CI 0.89–2.09). Among patients above the benefit threshold, the observed mortality was 52.0% (13 deaths) compared to 68.2% as per the baseline model (16.5 deaths; standardized mortality rate 0.61, 95% CI 0.39–0.92). Multivariable analyses identified lower lactate, the absence of cardiac arrest prior to ECMO, and the central cannulation (OR 0.31, 95% CI 0.10–0.98, p = 0.046) as significant predictors of survival for those treated with VA-ECMO. CONCLUSIONS: This binational study demonstrates that a rapidly available sepsis mortality prediction model can define thresholds for survival benefit in children with septic shock considered for ECMO. Survival on ECMO was associated with central cannulation. Our findings suggest that a fully powered RCT on ECMO in sepsis is unlikely to be feasible. |
format | Online Article Text |
id | pubmed-6937937 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-69379372019-12-31 Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study Schlapbach, Luregn J. Chiletti, Roberto Straney, Lahn Festa, Marino Alexander, Daniel Butt, Warwick MacLaren, Graeme Crit Care Research BACKGROUND: The surviving sepsis campaign recommends consideration for extracorporeal membrane oxygenation (ECMO) in refractory septic shock. We aimed to define the benefit threshold of ECMO in pediatric septic shock. METHODS: Retrospective binational multicenter cohort study of all ICUs contributing to the Australian and New Zealand Paediatric Intensive Care Registry. We included patients < 16 years admitted to ICU with sepsis and septic shock between 2002 and 2016. Sepsis-specific risk-adjusted models to establish ECMO benefit thresholds with mortality as the primary outcome were performed. Models were based on clinical variables available early after admission to ICU. Multivariate analyses were performed to identify predictors of survival in children treated with ECMO. RESULTS: Five thousand sixty-two children with sepsis and septic shock met eligibility criteria, of which 80 (1.6%) were treated with veno-arterial ECMO. A model based on 12 clinical variables predicted mortality with an AUROC of 0.879 (95% CI 0.864–0.895). The benefit threshold was calculated as 47.1% predicted risk of mortality. The observed mortality for children treated with ECMO below the threshold was 41.8% (23 deaths), compared to a predicted mortality of 30.0% as per the baseline model (16.5 deaths; standardized mortality rate 1.40, 95% CI 0.89–2.09). Among patients above the benefit threshold, the observed mortality was 52.0% (13 deaths) compared to 68.2% as per the baseline model (16.5 deaths; standardized mortality rate 0.61, 95% CI 0.39–0.92). Multivariable analyses identified lower lactate, the absence of cardiac arrest prior to ECMO, and the central cannulation (OR 0.31, 95% CI 0.10–0.98, p = 0.046) as significant predictors of survival for those treated with VA-ECMO. CONCLUSIONS: This binational study demonstrates that a rapidly available sepsis mortality prediction model can define thresholds for survival benefit in children with septic shock considered for ECMO. Survival on ECMO was associated with central cannulation. Our findings suggest that a fully powered RCT on ECMO in sepsis is unlikely to be feasible. BioMed Central 2019-12-30 /pmc/articles/PMC6937937/ /pubmed/31888705 http://dx.doi.org/10.1186/s13054-019-2685-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Schlapbach, Luregn J. Chiletti, Roberto Straney, Lahn Festa, Marino Alexander, Daniel Butt, Warwick MacLaren, Graeme Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study |
title | Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study |
title_full | Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study |
title_fullStr | Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study |
title_full_unstemmed | Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study |
title_short | Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study |
title_sort | defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937937/ https://www.ncbi.nlm.nih.gov/pubmed/31888705 http://dx.doi.org/10.1186/s13054-019-2685-1 |
work_keys_str_mv | AT schlapbachluregnj definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy AT chilettiroberto definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy AT straneylahn definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy AT festamarino definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy AT alexanderdaniel definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy AT buttwarwick definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy AT maclarengraeme definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy AT definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy |